Clinical Trial Update: Switching From Generic Selective Serotonin Reuptake Inhibitors (SSRIs) and Selective Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) to Three Different Dose Initiation Strategies With Vilazodone [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating three different dose initiation strategies for vilazodone after switching from generic SSRIs/SNRIs in adults with major depressive diso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Viibryd (vilazodone)

Snippet

Sponsor: Duke University | Conditions: Major Depressive Disorder (MDD) | Phase 3 | Status: COMPLETED | Results posted: 2015-02-09